Raymond James & Associates Buys 70,999 Shares of Kimberly-Clark Co. (NYSE:KMB)

Raymond James & Associates boosted its stake in shares of Kimberly-Clark Co. (NYSE:KMB) by 5.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,415,085 shares of the company’s stock after purchasing an additional 70,999 shares during the period. Raymond James & Associates owned about 0.42% of Kimberly-Clark worth $183,041,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in KMB. OFI Invest Asset Management purchased a new stake in Kimberly-Clark during the third quarter valued at $25,000. Rise Advisors LLC grew its stake in shares of Kimberly-Clark by 926.3% during the 1st quarter. Rise Advisors LLC now owns 195 shares of the company’s stock valued at $25,000 after purchasing an additional 176 shares during the period. Cranbrook Wealth Management LLC increased its position in shares of Kimberly-Clark by 90.9% during the 4th quarter. Cranbrook Wealth Management LLC now owns 210 shares of the company’s stock valued at $26,000 after purchasing an additional 100 shares during the last quarter. Accordant Advisory Group Inc bought a new position in shares of Kimberly-Clark in the 1st quarter worth approximately $27,000. Finally, Centerpoint Advisors LLC boosted its holdings in shares of Kimberly-Clark by 175.0% in the third quarter. Centerpoint Advisors LLC now owns 275 shares of the company’s stock worth $33,000 after buying an additional 175 shares during the last quarter. Institutional investors own 76.29% of the company’s stock.

Insider Buying and Selling

In other news, Director Mark T. Smucker bought 827 shares of Kimberly-Clark stock in a transaction dated Monday, January 29th. The shares were acquired at an average price of $120.98 per share, with a total value of $100,050.46. Following the completion of the purchase, the director now owns 827 shares in the company, valued at approximately $100,050.46. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, insider Paula Ramos sold 10,178 shares of the business’s stock in a transaction on Wednesday, April 24th. The stock was sold at an average price of $137.17, for a total transaction of $1,396,116.26. Following the completion of the transaction, the insider now owns 795 shares in the company, valued at approximately $109,050.15. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Mark T. Smucker purchased 827 shares of the firm’s stock in a transaction dated Monday, January 29th. The shares were bought at an average cost of $120.98 per share, with a total value of $100,050.46. Following the purchase, the director now directly owns 827 shares of the company’s stock, valued at approximately $100,050.46. The disclosure for this purchase can be found here. 0.62% of the stock is owned by corporate insiders.

Kimberly-Clark Price Performance

Shares of NYSE:KMB traded down $1.19 during mid-day trading on Friday, reaching $135.24. The stock had a trading volume of 2,123,919 shares, compared to its average volume of 2,437,404. The business’s 50 day moving average price is $125.86 and its 200 day moving average price is $122.92. Kimberly-Clark Co. has a 1 year low of $116.32 and a 1 year high of $147.09. The company has a market cap of $45.54 billion, a P/E ratio of 24.86, a price-to-earnings-growth ratio of 3.86 and a beta of 0.40. The company has a current ratio of 0.81, a quick ratio of 0.54 and a debt-to-equity ratio of 6.05.

Kimberly-Clark (NYSE:KMB) last posted its quarterly earnings data on Tuesday, April 23rd. The company reported $2.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.61 by $0.40. The business had revenue of $5.15 billion during the quarter, compared to analyst estimates of $5.08 billion. Kimberly-Clark had a return on equity of 250.28% and a net margin of 9.05%. The company’s revenue for the quarter was down .9% on a year-over-year basis. During the same period last year, the company earned $1.67 EPS. Research analysts expect that Kimberly-Clark Co. will post 7 EPS for the current fiscal year.

Analyst Ratings Changes

KMB has been the subject of a number of research reports. JPMorgan Chase & Co. upped their target price on shares of Kimberly-Clark from $115.00 to $123.00 and gave the company an “underweight” rating in a report on Wednesday. The Goldman Sachs Group raised their target price on Kimberly-Clark from $135.00 to $152.00 and gave the stock a “buy” rating in a report on Wednesday. UBS Group boosted their price target on Kimberly-Clark from $135.00 to $138.00 and gave the company a “neutral” rating in a report on Wednesday. Wells Fargo & Company lifted their price objective on Kimberly-Clark from $131.00 to $136.00 and gave the company an “equal weight” rating in a research report on Wednesday. Finally, Royal Bank of Canada increased their target price on shares of Kimberly-Clark from $123.00 to $126.00 and gave the stock a “sector perform” rating in a report on Wednesday. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $134.85.

Kimberly-Clark Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.